Published November 30, 2021 | Version v2
Other Open

Preventing RA - What treatments do people at risk of rheumatoid arthritis prefer?

  • 1. University of Birmingham, UK
  • 2. patient research partner, Sweden
  • 3. patient research partner, UK
  • 4. Erasmus University Rotterdam, Netherlands
  • 5. Janssen R&D, USA

Description

Rheumatoid arthritis, often referred to as RA, is a long-term condition that mainly affects the joints. RA causes pain, swelling, stiffness and often fatigue. If patients are not treated, their joints can suffer permanent damage, which can lead to disability. Having RA can also lead to other conditions, for example inflammation in other parts of the body like the lungs, heart or eyes. Most patients need long-term treatment with medicines that come with the risk of side effects that can be serious.

 

This case study was conducted within the PREFER project.

Files

PREFER Preventing Rheumatoid Arthritis.pdf

Files (1.0 MB)

Name Size Download all
md5:4c1ae81d4861a1e1a7d5b3526da584df
507.1 kB Preview Download
md5:eb18bb2038451604bb8150400f0656df
510.5 kB Preview Download

Additional details

Funding

PREFER – Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 115966
European Commission